Scientific Study Reveals E-cigarettes Can Alter Human DNA

Industry Insight by 2FIRSTS.ai
Apr.08.2024
Scientific Study Reveals E-cigarettes Can Alter Human DNA
Scientists from the University of California and the University of Innsbruck have found e-cigarettes can alter human DNA, research shows.

According to a report from Secretmag, scientists have discovered that e-cigarettes can alter human DNA. Scientists from the University of California (USA) and the University of Innsbruck (Austria) have found that changes in cheek cells are similar to those observed in regular cigarette smokers. They analyzed the epigenome, which is the information layer of DNA. Over 3,500 people participated in this new study.

 

According to Professor Martin Vidshvendtera, studying the phenotype genome of cells allows us to understand how the body responds to environmental factors such as smoking. He said, "In the same way, studying the phenotype genome can also help us predict future health conditions and diseases.

 

According to the latest scientific research, scientists have concluded through experiments that the population of people who use traditional tobacco and e-cigarettes have almost identical changes in their phenotypic genome. This phenomenon has even been observed in individuals who smoke less than 100 cigarettes. The changes in the phenotypic genome result in cancer cells growing faster within the epithelium.

 

Researchers believe that this new study confirms a theory that e-cigarettes are not as safe as the general public believes. Scientists at the University of Pittsburgh in the United States previously found that mint-flavored e-liquid is the least healthy option. This is because it produces the highest amount of toxic particles when mixed with other substances.

 

The consequences on the body include worsening lung function. Research has found that individuals who inhale menthol have less lung capacity compared to those who inhale other substances, regardless of age.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
Imperial Responds to 2Firsts: Disappointed by FDA Denial of blu Product
2Firsts interviewed Imperial Brands on FDA’s blu denial. ITG Brands responded with disappointment, vowing to pursue a fair, science-based review.
Aug.22
Indonesia's e-cigarette industry expected to create 210,000-280,000 jobs by 2030, with tax revenue reaching 2.65 trillion Indonesian Rupiah in 2024
Indonesia's e-cigarette industry expected to create 210,000-280,000 jobs by 2030, with tax revenue reaching 2.65 trillion Indonesian Rupiah in 2024
E-Cigarette Industry in Indonesia Expected to Create Up to 280,000 Jobs by 2030, Boosting Tax Revenue.
Sep.26 by 2FIRSTS.ai
Thai police seized 559,000 e-cigarettes worth $2.83 million, including INFY and Escobar brands
Thai police seized 559,000 e-cigarettes worth $2.83 million, including INFY and Escobar brands
Thai authorities seized 559,000 illicit e-cigarettes and parts, valued at around 90 million baht (≈$2.83 million), from a Saraburi warehouse. The haul included INFY and Escobar products. Suspects remain at large as the investigation continues.
Sep.11 by 2FIRSTS.ai
2Firsts Connect @ InterTabac Concludes Successfully — Spotlight on Global Landscape, Market Shifts, and Future Opportunities
2Firsts Connect @ InterTabac Concludes Successfully — Spotlight on Global Landscape, Market Shifts, and Future Opportunities
2Firsts Connect @ InterTabac concluded successfully under the theme “From Change to Opportunity,” focusing on the global harm-reduction landscape, shifts in the U.S. market, dynamics in China’s supply chain, vaping product trends, and capital-market opportunities. 2Firsts International Editor-in-Chief Taco Tuinstra, compliance expert Kurt Yang, co-founder Echo Guo, and CEO Alan Zhao shared frontline insights, drawing on UK MHRA registration data and China customs export data to present a compreh
Sep.20
Exhibitor Update|German Customs in Plainclothes Raid E-cigarette Booths, Untaxed Products Seized
Exhibitor Update|German Customs in Plainclothes Raid E-cigarette Booths, Untaxed Products Seized
German customs officers in plainclothes raided InterTabac 2025 in Dortmund, seizing and fining untaxed e-cigarettes on the spot, with multiple booths already inspected.
Sep.19 by 2FIRSTS.ai
The Indonesian National Narcotics Agency: Will not directly follow Singapore's ban on e-cigarettes; any ban must be based on real data
The Indonesian National Narcotics Agency: Will not directly follow Singapore's ban on e-cigarettes; any ban must be based on real data
The head of Indonesia's National Narcotics Agency stated that whether Indonesia will follow Singapore in banning e-cigarettes requires further research and multi-stakeholder discussions. He noted that some e-cigarettes are being used as a medium for drug delivery, but any ban must be supported by real data.
Aug.26 by 2FIRSTS.ai